India  
 
NewsR.in

BBV152

Vaccine against COVID-19

BBV152    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

BBV152: Vaccine against COVID-19
BBV152 is an inactivated virus based COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

0
shares		ShareTweetSavePostSend
 

Watch: Nepal's Foreign Minister meets EAM Jaishankar in Delhi l Key details [Video]

Watch: Nepal's Foreign Minister meets EAM Jaishankar in Delhi l Key details

External Affairs Minister S Jaishankar met his Nepalese counterpart Pradip Kumar Gyawali at the Hyderabad house in the capital. The two sides discussed all bilateral issues with focus on economy,..

Credit: HT Digital Content     Duration: 02:30Published
Covaxin, Covishield are safe, there is no difference between both: Shivraj Chouhan [Video]

Covaxin, Covishield are safe, there is no difference between both: Shivraj Chouhan

Madhya Pradesh Chief Minister Shivraj Singh Chouhan said that both Covaxin and Covishield have been properly tested. He said, "Our scientists have tested them on all parameters and only then it has..

Credit: ANI     Duration: 01:47Published
‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist [Video]

‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist

Dr Samiran Panda, scientist, India Council of Medical Research (ICMR) said that Bharat Biotech’s Covaxin will also provide immunity against covid-19 mutants. Panda added that India has taken a smart..

Credit: HT Digital Content     Duration: 04:36Published
Covishield and Covaxin are safe, assures ICMR scientist [Video]

Covishield and Covaxin are safe, assures ICMR scientist

Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda while speaking to ANI assured that both Covishield and Covaxin are safe and..

Credit: ANI     Duration: 02:29Published
Covaxin's immunity will address mutants too: ICMR scientist [Video]

Covaxin's immunity will address mutants too: ICMR scientist

Indian Council of Medical Research, Scientist and Head of Epidemiology and Communicable Diseases Division, Dr. Samiran Panda said that the immunity produced by the Covaxin is expected to address the..

Credit: ANI     Duration: 01:24Published
‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval [Video]

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the..

Credit: HT Digital Content     Duration: 01:40Published
Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch [Video]

Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch

Delhi Chief Minister Arvind Kejriwal commented on the impending launch of mass immunisation against Covid-19. India will begin vaccinations on January 16. Vaccines are being shipped to various centres..

Credit: HT Digital Content     Duration: 02:39Published
Indians are not guinea pigs: Manish Tewari on rollout of Covaxin [Video]

Indians are not guinea pigs: Manish Tewari on rollout of Covaxin

Congress MP Manish Tewari raised objection on the rollout of Covaxin. Manish Tewari said that government should either not roll out Covaxin till its efficacy and reliability is completely established..

Credit: ANI     Duration: 01:10Published
Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield [Video]

Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield

The first batch of Covaxin landed at the Delhi airport from Hyderabad on January 13. The Covid-19 vaccine by Bharat Biotech was brought in by two flights. An Air India flight landed with 3 boxes while..

Credit: HT Digital Content     Duration: 02:02Published
First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport [Video]

First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport

The first consignment of 'Covaxin', the COVID-19 vaccine by Hyderabad-based Bharat Biotech arrived at Delhi's Indira Gandhi International Airport on Jan 13. Three boxes of 'Covaxin' are also being..

Credit: ANI     Duration: 01:18Published
Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out [Video]

Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out

Several states in India received the vaccine doses on January 12. Consignment of Covishield was dispatched from Serum Institute of India, Pune. States that received vaccines on January 12 include..

Credit: HT Digital Content     Duration: 03:31Published
‘Both vaccines are safe for use’: Centre ahead of vaccination roll-out in India [Video]

‘Both vaccines are safe for use’: Centre ahead of vaccination roll-out in India

Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member..

Credit: HT Digital Content     Duration: 07:42Published
Covid: How much will Covishield, Covaxin, other vaccines cost? Centre reveals [Video]

Covid: How much will Covishield, Covaxin, other vaccines cost? Centre reveals

Union Health Secretary Rajesh Bhushan on Tuesday said the COVID-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines -- Covishield and Covaxin -- have received Emergency Use..

Credit: HT Digital Content     Duration: 06:57Published
BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry [Video]

BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry

Bharat Biotech to provide 16.50 lakh doses of COVAXIN for free of cost to the Central government as a special gesture, informed Union Health Ministry during a press briefing on January 12. "The..

Credit: ANI     Duration: 01:23Published
Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy [Video]

Around 5.56 lakh COVID vaccine doses dispatched from Pune: TN Principal Health Secy

On January 12, the Principal Secretary of Health and Family Welfare Department of Tamil Nadu, J Radhakrishnan spoke on COVID-19 vaccine distribution process. He said, "Around 5.56 lakh vaccine doses..

Credit: ANI     Duration: 02:22Published
Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move [Video]

Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move

On the day that the Union government announced the launch date of Covid-19 vaccination in the country, Chhattisgarh health minister TS Singh Deo made an appeal. The Congress leader said that the Centre..

Credit: HT Digital Content     Duration: 03:58Published

You Might Like


Vaccine drive accelerates, doses reach far corners of India

While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
IndiaTimes - Published

Bharat Biotech commences dispatch of Covaxin, ships to 11 cities

Vaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown out of Hyderabad by national carrier..
IndiaTimes - Published

After Covishield, first batch of Bharat Biotech's Covaxin arrives in Delhi

Both Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government.
DNA - Published

Covid vaccine recipients may not be able to pick & choose

Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they..
IndiaTimes - Published

Covishield, Covaxin are safest of Covid-19 vaccines, side-effects are negligible: VK Paul

Covishield and Covaxin, the two Covid-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member..
IndiaTimes - Published

Bharat Biotech inks pact to supply Covaxin to Brazil

Vaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian..
IndiaTimes - Published

Gas activists request PM to stop vaccine trials in Bhopal

Organisations working with Bhopal gas disaster victims on Sunday urged PM Modi to stop the clinical trial of Covaxin in Bhopal, alleging irregularities in process and protocol. The activists have..
IndiaTimes - Published

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-March

Buoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new..
IndiaTimes - Published

Supply order for Covid vax likely to be placed today

Covishield and Covaxin, the two vaccines accorded emergency use approval, are on the verge of being available in the country, health minister Harsh Vardhan said on Thursday, adding that a mega..
IndiaTimes - Published

Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials


IndiaTimes - Published

Covid-19 vaccines 'Covishield', 'Covaxin' to be available soon in India


IndiaTimes - Published

No irregularity in approval to Covaxin: ICMR

In an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2..
IndiaTimes - Published

All-India vaccine rollout set for next week: Govt

The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
IndiaTimes - Published

Zee News journalist, who had taken Covaxin shot, feels feverish the day after

Zee News reporter Pooja Makkar, who became the first Indian woman journalist to receive the indigenously developed COVID-19 vaccine 'Covaxin', on Tuesday evening said that she has a slight fever and a..
DNA - Published

Carried out 200% honest trials, don't deserve this backlash: Bharat Biotech hits back at critics

Some opposition leaders and scientific researchers criticised Covaxin for being given emergency use authorisation without completion of phase 3 trials
DNA - Published

Vaccine war: Bharat Biotech chief lashes out at Serum

Bharat Biotech founder and chairman Dr Krishna Ella on Monday lashed out at detractors who criticised the speed at which emergency use authorisation (EUA) was given to Covaxin, the company’s Covid-19..
IndiaTimes - Published

Covaxin not water-like or backup vaccine, trials 200% honest: Bharat Biotech CEO


IndiaTimes - Published

Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021

The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday. "We have four facilities coming up and we are planning (to make) around 200 million doses in..
IndiaTimes - Published

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being "targeted by everyone in the world" for..
IndiaTimes - Published

DCGI allows Bharat Biotech to conduct vaccine trials on children above 12

Covaxin has already been used on children above 12 in phase I and II trials and has been found safe.
DNA - Published

Covid: Both vaccines get final nod, first shots to be of Covishield

The Serum Institute of India’s Covishield is likely to be first shot used in India’s vaccine drive against Covid-19. For Covaxin, the authorisation is in clinical-trial mode, which means that..
IndiaTimes - Published

Vaccine approval process opaque: Experts

Former president of the International Association of Bioethics, Dr Anant Bhan, pointed out that the only other countries to approve vaccines without making the efficacy data public were Russia and..
IndiaTimes - Published

ICMR says clinical trial shows COVAXIN is 'safe'

Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
DNA - Published

Covid-19: India approves Covaxin and Covishield vaccines; Congress expresses concern over Covaxin trial data


IndiaTimes - Published

Great milestone in India's scientific capability: Bharat Biotech after DCGI approval to Covaxin

The Hyderabad-based vaccine maker expressed its delight after DCGI granted permission for emergency use of its Covid-19 vaccine.
DNA - Published

'Watershed moment in India's battle against COVID': Politicos react over emergency use approval

DCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
DNA - Published

DCGI approves Oxford's Covishield and Bharat Biotech's Covaxin vaccines for restricted emergency use


IndiaTimes - Published

COVID-19: Bharat Biotech recruits 23,000 volunteers for Phase III trials of Covaxin

The phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.
DNA - Published Also reported by •IndiaTimes

Bharat Biotech’s Covaxin too gets nod for emergency use

India's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
IndiaTimes - Published

After Covishield, India's Covaxin gets expert panel nod for emergency use

An expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use..
IndiaTimes - Published

Covaxin vaccine: DCGI panel to meet Bharat Biotech officials shortly


IndiaTimes - Published

No approval for Covaxin, expert panel seeks more data from Bharat Biotech

The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for..
IndiaTimes - Published

Covaxin can offer protection against mutated coronavirus: Bharat Biotech

Vaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain.
DNA - Published

Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah Naidu

They discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans..
IndiaTimes - Published

Indian vaccine Covaxin has drawn global attention: ICMR

The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against..
IndiaTimes - Published

Covaxin Phase III trials hit halfway mark with 13K volunteers

Covaxin, India's first indigenous Covid-19 vaccine being developed by Hyderabad-based Bharat Biotech, has been successful in roping in 13,000 volunteers for its Phase III trials, which is half the..
IndiaTimes - Published